HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Appendiceal orifice inflammation in distal ulcerative colitis. Report of a case and review of the literature].

Abstract
We report the case of a 45-year-old female patient with an 18 month diagnosis of distal ulcerative colitis (proctosigmoiditis) of 18 months, who presented initially with allergy to salicylates, for which the disease was managed with corticosteroids and azathioprine and subsequently with Infliximab infusions, entering in remission. When she was about to receive her fifth Infliximab infusion she presented an exacerbation of her underlying disease with frequent stools with mucus, blood and tenesmus. Given that her initial diagnosis was made with a sigmoidoscopy we scheduled a total colonoscopy showing marked inflammation, erythema and friability limited to the recto-sigmoid mucosa, like at the disease onset, and when we reached the cecum an erythematous area circumscribed to the appendiceal orifice was observed, with a mucosal aspect identical to the described for the recto-sigmoid mucosa. The biopsies taken from that area were compatible with ulcerative colitis. We herein describe the details of the case and review the literature.
AuthorsMartin Tagle, Yolanda Scavino, Eduardo Luna
JournalRevista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru (Rev Gastroenterol Peru) 2010 Jul-Sep Vol. 30 Issue 3 Pg. 228-31 ISSN: 1022-5129 [Print] Peru
Vernacular TitleInflamación del Orificio Apendicular en Colitis Ulcerativa Distal.
PMID20924432 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab
Topics
  • Anti-Inflammatory Agents (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Appendicitis (etiology, pathology)
  • Appendix (pathology)
  • Biopsy
  • Colon (pathology)
  • Female
  • Gastrointestinal Agents (administration & dosage, therapeutic use)
  • Humans
  • Infliximab
  • Intestinal Mucosa (pathology)
  • Middle Aged
  • Proctocolitis (complications, drug therapy, pathology)
  • Remission Induction
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: